Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04382248 · ClinicalTrials.gov registry record · NA
The Integration of a Mobile App Platform With Biomarkers in Kidney Transplantation
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT04382248 is a NA study that has completed, run by Duke University. The registered enrollment target is 22 participants.
The verdict
NCT04382248, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the feasibility and acceptability of a mobile app to improve self-management skills and medication adherence in kidney transplantation, to assess the clinical benefit of mobile app in combination with tailored coaching using text messaging to enhance patient activation, self-management and medication adherence and to determine whether immunological biomarkers such as cell-free DNA and donor specific antibodies are associated with self-management and medication adherence.
Interventions
- OTHER Smartphone App
- BEHAVIORAL Tailored education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-10-15 |
| Est. Completion | 2021-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04382248
The ClinicalTrials.gov registry entry for NCT04382248 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Smartphone App is the first listed.
NCT04382248 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04382248 about?
NCT04382248 is a clinical study titled "The Integration of a Mobile App Platform With Biomarkers in Kidney Transplantation". The purpose of this study is to examine the feasibility and acceptability of a mobile app to improve self-management skills and medication adherence in kidney transplantation, to assess the clinical benefit of mobile app in combination with tailored coaching using text messaging to enhance patient a...
What is the current status of trial NCT04382248?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2020-10-15. Estimated completion is 2021-11-30.
What interventions are being tested in trial NCT04382248?
The interventions under investigation include: Smartphone App (OTHER), Tailored education (BEHAVIORAL).
Who is sponsoring clinical trial NCT04382248?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.